Finasteride Delayed-Onset Side Effects: What the Evidence Actually Shows
Trial data on when finasteride sexual side effects were reported, label wording on effects after stopping, and cohort data on depression.
6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
Trial data on when finasteride sexual side effects were reported, label wording on effects after stopping, and cohort data on depression.
Most finasteride side effects fade after stopping, but some men report lasting sexual and mood changes, per the FDA label and studies. See the data.
A data-driven breakdown of finasteride adverse event rates from PLESS, PCPT, MTOPS, and FDA FAERS reports, with direct trial statistics and clinical context.
Finasteride has no boxed warning, but labels list high-grade prostate cancer, persistent sexual dysfunction, depression and suicidal ideation.
A breakdown of finasteride adverse events by severity and patient phenotype, drawing on PCPT trial data, FDA FAERS reports, and post-market literature to help patients and prescribers understand real-world risk.
A clinical review of finasteride withdrawal and discontinuation syndrome, including post-finasteride syndrome, persistent side effects, FAERS data, and what to expect when stopping the drug.